Kinase inhibitors for advanced medullary thyroid carcinoma

AUTOR(ES)

Schlumberger, Martin, Massicotte, Marie-Hélène, Nascimento, Camila L., Chougnet, Cécile, Baudin, Eric, Leboulleux, Sophie

FONTE

Clinics

DATA DE PUBLICAÇÃO

2012

RESUMO

The recent availability of molecular targeted therapies leads to a reconsideration of the treatment strategy for patients with distant metastases from medullary thyroid carcinoma. In patients with progressive disease, treatment with kinase inhibitors should be offered.

Documentos Relacionados

• Improved results of cervical reoperation for medullary thyroid carcinoma.
• Histogenesis of medullary carcinoma of the thyroid
• Eye manifestations in medullary carcinoma of the thyroid.
• Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma
• Medullary carcinoma of the thyroid with carcinoid-like features.